FDA Approved: RIZATRIPTAN BENZOATE — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved Cipla USA's supplemental application for Rizatriptan Benzoate, enabling its marketing as an approved generic product for the acute treatment of mig…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Rizatriptan Benzoate (rizatriptan benzoate)

Snippet

SUPPL AP for RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE)